⌘K

Login Start Free

Home/Filings/4/0001437749-20-012480

4//SEC Filing

Latkin Jed 4

Accession 0001437749-20-012480

CIK 0000810509other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:18 PM ET

Size

4.4 KB

Accession

0001437749-20-012480

Insider Transaction Report

Form 4

Period: 2020-06-02

NAVIDEA BIOPHARMACEUTICALS, INC.NAVB

Interim COO

Transactions

Award
Common Stock
2020-06-02$2.62/sh+33,997$89,072→ 57,997 total

Footnotes (1)

[F1]Stock granted under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1

filerCIK 0001554593

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 4:18 PM ET
Size: 4.4 KB

View on SEC.gov